Metabolomics paves the way for improved drug target identification
Open Access
- 1 February 2022
- journal article
- research article
- Published by Springer Nature in Molecular Systems Biology
- Vol. 18 (2) , e10914
Abstract
Correctly identifying candidate drugs for protein targets is crucial for drug discovery. Despite the importance of this problem for the pharmaceutical industry, chemical screening remains a challenging task, and drug–target misidentification may contribute to failures in drug development. In their recent study, Sauer and colleagues (Holbrook‐Smith et al , 2022) demonstrate proof‐of‐concept for a new way to identify drug–target interactions using high‐throughput metabolomics, potentially paving the way towards a universal method for predicting drug–target relationships.Keywords
This publication has 9 references indexed in Scilit:
- High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteinsMolecular Systems Biology, 2022
- The landscape of metabolic pathway dependencies in cancer cell linesPLOS Computational Biology, 2021
- Estimation of clinical trial success rates and related parametersBiostatistics, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- Nutrient sensing and TOR signaling in yeast and mammalsThe EMBO Journal, 2017
- Tracking cancer drugs in living cells by thermal profiling of the proteomeScience, 2014
- Metabolomics: the apogee of the omics trilogyNature Reviews Molecular Cell Biology, 2012
- High-Throughput, Accurate Mass Metabolome Profiling of Cellular Extracts by Flow Injection–Time-of-Flight Mass SpectrometryAnalytical Chemistry, 2011
- Functional Discovery via a Compendium of Expression ProfilesCell, 2000